Guidelines for specialized nutritional and metabolic support in the critically-ill patient: update. Consensus SEMICYUC-SENPE: oncohematological patient

Nutr Hosp. 2011 Nov:26 Suppl 2:50-3. doi: 10.1590/S0212-16112011000800011.

Abstract

Patients with cancer, irrespective of the stage of their disease, can require admission to the intensive care unit as a result of the complications of their underlying process or the surgical or pharmacological treatment provided. The cancer itself, as well as the critical status that can result from the complications of the disease, frequently lead to a high degree of hypermetabolism and inadequate energy intake, causing a high incidence of malnutrition in these patients. Moreover, cancer causes anomalous use of nutritional substrates and therefore the route of administration and proportion and intake of nutrients may differ in these patients from those in noncancer patients.

Publication types

  • Guideline
  • Review

MeSH terms

  • Consensus
  • Critical Illness / therapy*
  • Dietary Fats / administration & dosage
  • Dietary Proteins / administration & dosage
  • Eicosapentaenoic Acid / administration & dosage
  • Eicosapentaenoic Acid / therapeutic use
  • Energy Intake
  • Enteral Nutrition / methods
  • Glutamine / administration & dosage
  • Glutamine / therapeutic use
  • Hematologic Neoplasms / metabolism
  • Hematologic Neoplasms / therapy*
  • Humans
  • Nutritional Requirements
  • Nutritional Support / methods*
  • Parenteral Nutrition / methods
  • Trace Elements / administration & dosage
  • Trace Elements / therapeutic use
  • Vitamins / administration & dosage
  • Vitamins / therapeutic use

Substances

  • Dietary Fats
  • Dietary Proteins
  • Trace Elements
  • Vitamins
  • Glutamine
  • Eicosapentaenoic Acid